The SignatureDx Blog

webinar - expanded cfDNA based Prenatal Testing

Webinar | Expanded cfDNA-based Prenatal Testing

white paper_ Screening for Fetal ChromosomalAbnormalities

White Paper | ACOG – Screening for Chromosomal Abnormalities

Home » Copy of White Paper | Considerations When Ordering Non-invasive Prenatal Screening (NIPS) Screening for Fetal Chromosomal Abnormalities Prenatal testing for chromosomal abnormalities is designed to provide an accurate assessment of a patient’s risk of carrying a fetus with a chromosomal disorder. A wide variety of prenatal screening and diagnostic tests are available; each …

White Paper | ACOG – Screening for Chromosomal Abnormalities Read More »

Considerations When Ordering Non-invasive  Prenatal Screening  (NIPS)

White Paper | Considerations When Ordering Non-invasive Prenatal Screening (NIPS)

Home » Copy of White Paper | Whole-Genome Sequencing Provides the Most Informative Noninvasive Prenatal Testing Results Considerations When Ordering Non-invasive Prenatal Screening (NIPS) NIPS generally relies on blood testing from the mother to reveal information from circulating cell-free DNA (cfDNA) from the placenta, which can be identified in the maternal plasma from five weeks …

White Paper | Considerations When Ordering Non-invasive Prenatal Screening (NIPS) Read More »

Study_ NIPT in the general population

White Paper | Whole-Genome Sequencing Provides the Most Informative Noninvasive Prenatal Testing Results

Home » Copy of SignatureDx – What We Do Whole-Genome Sequencing Provides the Most Informative Noninvasive Prenatal Testing Results A comparative analysis of commercially available methods for noninvasive prenatal tests. Download PDF

signaturedx-overview-image

SignatureDx – What We Do

Home » SignatureDx – What We Do SignatureDx Resources – What We Do One Pager Download PDF

David Peters, Photo Credit: Magee Women's Research Institute

Rooted in Research: NIPT and the Story of Dave Peters

Rooted in Research: NIPT and the Story of Dave Peters At SignatureDx, we’re driven to advance the field of early detection diagnostics through noninvasive technology. We uphold our core values in all aspects of our work, and our research collaborators share the SignatureDx passion to help change the paradigm of healthcare. A founding component of …

Rooted in Research: NIPT and the Story of Dave Peters Read More »